A detailed history of Etesian Wealth Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Etesian Wealth Advisors, Inc. holds 11,961 shares of ABT stock, worth $1.39 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
11,961
Previous 12,192 1.89%
Holding current value
$1.39 Million
Previous $1.27 Billion 7.64%
% of portfolio
0.62%
Previous 0.71%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$100.07 - $118.13 $23,116 - $27,288
-231 Reduced 1.89%
11,961 $1.36 Billion
Q2 2024

Jul 25, 2024

BUY
$100.73 - $112.44 $21,757 - $24,287
216 Added 1.8%
12,192 $1.27 Billion
Q1 2024

Apr 12, 2024

SELL
$109.52 - $120.96 $16,099 - $17,781
-147 Reduced 1.21%
11,976 $1.36 Billion
Q4 2023

Jan 16, 2024

SELL
$90.19 - $110.4 $23,990 - $29,366
-266 Reduced 2.15%
12,123 $1.34 Billion
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $23,990 - $29,366
-266 Reduced 2.15%
12,123 $1.34 Billion
Q3 2023

Jan 16, 2024

SELL
$95.53 - $114.62 $4,107 - $4,928
-43 Reduced 0.35%
12,389 $1.2 Billion
Q3 2023

Oct 19, 2023

SELL
$95.53 - $114.62 $4,107 - $4,928
-43 Reduced 0.35%
12,389 $1.2 Billion
Q2 2023

Jan 16, 2024

SELL
$100.78 - $112.29 $23,078 - $25,714
-229 Reduced 1.81%
12,432 $1.36 Billion
Q2 2023

Oct 19, 2023

SELL
$100.78 - $112.29 $23,078 - $25,714
-229 Reduced 1.81%
12,432 $1.36 Billion
Q1 2023

Jan 16, 2024

BUY
$96.86 - $114.01 $3,196 - $3,762
33 Added 0.26%
12,661 $1.28 Billion
Q1 2023

Oct 19, 2023

BUY
$96.86 - $114.01 $3,196 - $3,762
33 Added 0.26%
12,661 $1.28 Billion
Q4 2022

Jan 16, 2024

BUY
$95.06 - $111.52 $48,005 - $56,317
505 Added 4.17%
12,628 $1.39 Billion
Q4 2022

Oct 19, 2023

BUY
$95.06 - $111.52 $1.2 Million - $1.41 Million
12,628 New
12,628 $1.39 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Etesian Wealth Advisors, Inc. Portfolio

Follow Etesian Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Etesian Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Etesian Wealth Advisors, Inc. with notifications on news.